Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 6;20:205. doi: 10.1186/s13075-018-1698-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 6 — Phenotypic analysis of T cells in mesenteric lymph nodes (MLNs) and cervical lymph nodes (CLNs) by flow cytometry after 4-week treatment with SR1001 or vehicle. CD4+ and IL-17+ cells in MLNs and CLNs were detected by flow cytometry after stimulation with phorbol-12-myristate-13-acetate (PMA) and ionomycin for 6 h (n = 3 for each group). CD4+ and IL-17+ double positive cells (T helper 17(Th17)) were decreased in MLNs and CLNs of non-obese diabetic (NOD) mice after 4-week SR1001treatment at both 4 weeks (4W) and 8 weeks (8W) of age (b, d) compared to vehicle groups (a, c)